Dual-layer spectral detector computed tomography multiparameter machine learning model for prediction of lymph node metastases in esophageal squamous cell carcinoma.
Source check: Source checked. Not independent scientific confirmation.
Finding: A multiparametric dual-layer spectral CT machine-learning model predicts lymph-node metastasis in esophageal squamous-cell carcinoma, with training- and test-cohort AUCs reported. Published in Cancer Imaging.
Technology: A multiparameter machine-learning model uses dual-layer spectral CT features to predict lymph-node metastasis in esophageal cancer.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- A multiparameter machine-learning model uses dual-layer spectral CT features to predict lymph-node metastasis in esophageal cancer.
- Test and result
- The full text describes the cohort or experimental system, comparison/reference, and internal/external or experimental validation used for the represented claim; no broader clinical benefit is inferred.
- Limitation / still unknown
- External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12924508/ · https://pubmed.ncbi.nlm.nih.gov/41612499/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.